상세 보기
Survival data from EMPOWER-Lung 4: Phase II study of cemiplimab plus ipilimumab in the second-line (2L) treatment of advanced non-small cell lung cancer (NSCLC)
- Shim, B. Y.;
- Lee, S.;
- de Castro Carpeno, J.;
- Chiu, C-H.;
- Cobo, M.;
- ... Ryu, J. S.;
- 외 7명
Citations
WEB OF SCIENCE
2- 제목
- Survival data from EMPOWER-Lung 4: Phase II study of cemiplimab plus ipilimumab in the second-line (2L) treatment of advanced non-small cell lung cancer (NSCLC)
- 저자
- Shim, B. Y.; Lee, S.; de Castro Carpeno, J.; Chiu, C-H.; Cobo, M.; Kim, H. R.; Majem Tarruella, M.; Summers, Y.; Ryu, J. S.; Thomas, C. A.; Xu, Y.; Lowy, I.; Rietschel, P.
- 발행일
- 2021-04
- 유형
- Meeting Abstract
- 권
- 16
- 호
- 4
- 페이지
- S760 ~ S760